Boehringer Ingelheim and Duke Clinical Research Institute Expand Collaboration to Create Largest Patient Registry for Idiopathic Pulmonary Fibrosis (IPF)

Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news
More News: Research